Sesamol combats diabetogenic effects of atorvastatin through GLUT-4 expression and improved pancreatic viability.

Autor: Keni, Raghuvir1 (AUTHOR), Nayak, Pawan Ganesh1 (AUTHOR), Kumar, Nitesh1,2 (AUTHOR), Kishore, Anoop1 (AUTHOR), Alnasser, Sulaiman Mohammed3 (AUTHOR), Begum, Farmiza1 (AUTHOR), Gourishetti, Karthik1 (AUTHOR), Nandakumar, Krishnadas1 (AUTHOR) mailnandakumar77@gmail.com
Zdroj: 3 Biotech. 10/24/2023, Vol. 13 Issue 11, p1-11. 11p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje